Literature DB >> 12901567

Needle-free epidermal powder immunization.

Dexiang Chen1, Yuh-Fun Maa, Joel R Haynes.   

Abstract

Due to the presence of a network of antigen-presenting cells and other cells with innate and adaptive immune functions, the skin is both a sensitive immune organ and a practical target site for vaccine administration. A handful of needle-free immunization technologies have emerged in recent years that aim to take advantage of these characteristics. Skin delivery technologies provide potentially safer alternatives to needle injection and promises increased efficacy in the prevention and/or therapy of infectious diseases, allergic disorders and cancer. In this review, we will cover advances in needle-free skin vaccination technologies and their potential applications to disease prevention and therapy. Emphasis will be placed on epidermal powder immunization and particle-mediated ('gene gun') DNA immunization, which use similar mechanical devices to deliver protein and DNA vaccines, respectively, into the viable epidermis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12901567     DOI: 10.1586/14760584.1.3.265

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  13 in total

1.  Performance studies of particle acceleration for transdermal drug delivery.

Authors:  Yi Liu
Journal:  Med Biol Eng Comput       Date:  2006-06-14       Impact factor: 2.602

Review 2.  Topical vaccination: the skin as a unique portal to adaptive immune responses.

Authors:  Chun-Ming Huang
Journal:  Semin Immunopathol       Date:  2007-04       Impact factor: 9.623

3.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

4.  Micro-fractional epidermal powder delivery for improved skin vaccination.

Authors:  Xinyuan Chen; Garuna Kositratna; Chang Zhou; Dieter Manstein; Mei X Wu
Journal:  J Control Release       Date:  2014-08-15       Impact factor: 9.776

Review 5.  Antigen-specific therapeutic approaches in Type 1 diabetes.

Authors:  Xavier Clemente-Casares; Sue Tsai; Carol Huang; Pere Santamaria
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 6.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

7.  Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization.

Authors:  Yuh-Fun Maa; Cassandra Shu; Mahmoud Ameri; Cindy Zuleger; Jenny Che; Jorge E Osorio; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

Review 8.  Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.

Authors:  Yuan Chen; Tarun Tejasvi Mutukuri; Nathan E Wilson; Qi Tony Zhou
Journal:  Adv Drug Deliv Rev       Date:  2021-03-08       Impact factor: 15.470

Review 9.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

Review 10.  Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.

Authors:  Xiaoyun Hong; Liangming Wei; Fei Wu; Zaozhan Wu; Lizhu Chen; Zhenguo Liu; Weien Yuan
Journal:  Drug Des Devel Ther       Date:  2013-09-04       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.